- Institute Event
- Défi des pompiers
march to september 2022 — Défi des pompiers
Défi des pompiers 2022
The Défi des pompiers 2022 is an initiative of Mr. Pierre Clermont, Montreal’s Fire Chief. It aims to raise funds for brain cancer research, to be donated to the Institut du cancer de Montréal. In September 2022, the Montreal Fire Chiefs Association donated $2859.43 to reach the $50,000 goal. Thank you to all the donors!
Supporting brain cancer research
Mr. Clermont, who is currently fighting brain cancer, wishes to mobilize the Quebec firefighters network by symbolically inviting his colleagues to perform 22 consecutive burpees.
Combining physical strength and surpassing oneself, this movement demonstrates the commitment and support emanating from the Quebec firefighters’ brotherhood.
Watch Pierre’s testimonial video here.
TWO WAYS TO CONTRIBUTE
- Participate and take the Défi des pompiers 2022. By choosing this option, we encourage you to make a donation of $25 or more by clicking on DONATE and selecting your contribution amount. We then invite you to film yourself completing YOUR 22 burpee challenge. Once you have completed the challenge, challenge a firefighter or someone you know by sharing your challenge on your social networks. Invite one of your colleagues or a member of your entourage to do the same to create a chain of mobilization. Don’t forget to identify the Institut du cancer de Montréal when sharing on your social networks.
- Donate and encourage the movement by clicking on the DONATE button and selecting the amount of your contribution.
By choosing one of these options, you are contributing to the advancement of brain cancer research. Every day, researchers at the Institute are working on innovative new treatments and making important discoveries. On behalf of these scientists, thank you for supporting research!
“Glioblastoma is the most common and unfortunately the most aggressive primary brain tumor. The development of new treatments represents a huge challenge, which is why this fundraiser is so important to contribute to brain cancer research.” – Dr. Sarah Lapointe